Dymon Asia Capital’s iKang Healthcare Group, Inc. KANG Stock Holding History

Dymon Asia Capital’s Portfolio KANG Stock Details KANG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-44,437	Closed	-$815K	–	12
2016 Q2	$815K	Sell	44,437 -36,326	-45%	-$731K	0.52%	11
2016 Q1	$1.76M	Buy	80,763 +8,700	+12%	+$181K	1.32%	9
2015 Q4	$1.47M	Buy	+72,063	New	+$1.24M	1.39%	7

Other funds holding KANG

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return

ASI

All-Stars Investment Hong Kong $206M AUM 31.57% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

KCM

Keywise Capital Management Grand Cayman, Cayman Islands $220M AUM 21.27% 1-Year Est. Return

Dymon Asia Capital's KANG Position: Q3 2016 in Review

Dymon Asia Capital sold out of iKang Healthcare Group, Inc. (KANG) in Q3 2016, closing a stake of 44,437 shares — an estimated $815K sold.

Dymon Asia Capital first reported a position in KANG in Q4 2015 and held it in 3 quarters. The position peaked at $1.76M in Q1 2016. 62 funds tracked by Wall St. Rank hold KANG as of Q3 2016.

Dymon Asia Capital reported no remaining iKang Healthcare Group, Inc. position as of Q3 2016 after selling out during the quarter.
Dymon Asia Capital sold 44,437 iKang Healthcare Group, Inc. shares in Q3 2016, an estimated $815K.
Dymon Asia Capital first reported a position in iKang Healthcare Group, Inc. in Q4 2015 and held it in 3 quarters.
Dymon Asia Capital's iKang Healthcare Group, Inc. position peaked at $1.76M in Q1 2016.
62 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q3 2016.

Based on Dymon Asia Capital's 13F filing for Q3 2016, filed 10 Nov 2016.